Biotech

All Articles

Novo inks $600M NanoVation offer to examine genetic medications ex-liver

.Novo Nordisk is continuing its push into genetic medicines, accepting to pay NanoVation Therapeutic...

Innovent hyperlinks cytokine to intestines cancer cells responses

.Innovent Biologics has created the case that its gate inhibitor-cytokine combination healthy protei...

Merck, Daiichi ADC reaches objective in period 3 lung cancer cells research

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina strengthens artificial intelligence focus with collab to pick cancer cells aim ats

.Five months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medication favorites in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a prospective danger to BioMarin's Voxzogo, reporting phase...

Despite ph. 3 miss out on, Alkeus sees course in advance for eye illness property

.Though Alkeus Pharmaceuticals' oral eye disease asset fell short to substantially reduce geographic...

Kairos goes public with $6M IPO to finance trials of cancer cells medication

.With a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to overlook a...

Vaccine and also Keytruda combination helpful in squamous cell carcinoma

.Invulnerable gate inhibitors are the superheroes of cancer cells therapy. Medicines like Bristol My...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant management hirings, firings as...

Regeneron's Opdualag rival shows 57% reaction cost

.Regeneron is back with long-term follow-up for its own LAG-3 inhibitor and also PD-1 prevention com...